Key result
Percutaneous closure of ventricular septal defects using various occlusion devices resulted in successful implantation in 75% (9/12) of patients and complete closure in 67% (8/12) within 24 hours.
Observational (n=12)
Percutaneous closure of congenital and acquired VSDs is feasible and achieves high short-term closure rates, though device instability and valve entrapment remain important procedural risks.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating in small case series; leaves open safety, durability, and role versus surgery in larger cohorts.
Michel‐Behnke et al. (2005) conducted an observational in Congenital and acquired ventricular septal defects (n=12). Percutaneous closure using occlusion devices was evaluated on Complete VSD closure within 24 hours. Percutaneous closure of ventricular septal defects using various occlusion devices resulted in successful implantation in 75% (9/12) of patients and complete closure in 67% (8/12) within 24 hours.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: